SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst a polarized community debate following a mixed earnings report with raised full-year guidance contrasted by near-term softness, as bulls emphasize continued growth and a substantial share buyback program while bears highlight escalating regulatory challenges and lawsuits surrounding its compounded GLP-1 offerings.

Seeker is building a decentralized mobile ecosystem designed to challenge entrenched mobile incumbents through its TEEPin network architecture and community governance. It aims to solve the pain points of centralized app store gatekeeping, lack of developer freedom, and restricted user access to crypto applications. The vision is to create a community-owned platform with decentralized governance, no gatekeepers, direct developer-user access, and TEEPin security architecture.

Saakuru

SKR (Seeker Solana Smartphone Token) is trending after its recent listing on major exchanges and an airdrop to Solana phone users, alongside a promotional offer for a significant discount on Seeker phone purchases when paid with SKR. The community is actively discussing its rapid price appreciation and utility within the Solana mobile ecosystem, while also debating potential profit-taking.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a high-stakes bidding war for Warner Bros. Discovery, where a rival's sweetened offer forces Netflix to decide whether to raise its bid or walk away, a decision complicated by heightened DOJ antitrust scrutiny and political pressure. Community sentiment is sharply divided, with many anticipating a stock rebound if Netflix forgoes the deal to shed acquisition-related overhangs.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending due to its new global collaboration with Astellas for the prostate cancer drug VIR-5500, which includes substantial upfront payments and milestone potential, bolstered by positive Phase 1 data showing promising anti-tumor activity. This has fueled widespread bullish sentiment and short squeeze speculation, though some market participants remain cautious about its price volatility.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending amidst a massive sell-off, fueled by investor fears that Anthropic's new AI tool for COBOL modernization threatens a key legacy business and signals broader AI disruption for IT services. However, the community is debating if this is an overreaction, pointing to IBM's internal AI capabilities and deep enterprise client relationships.

Amphenol Corp. engages in the design, manufacture, and marketing of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products, and specialty cable. It operates through the following segments: Harsh Environment Solutions, Communications Solutions, and Interconnect and Sensor Systems. The Harsh Environment Solutions segment manufactures and markets a broad range of ruggedized interconnect products, including connectors and interconnect systems, printed circuits and printed circuit assemblies, and other products. The Communications Solutions segment focuses on the design, manufacture, and marketing of connector and interconnect systems, including radio frequency, power, fiber optic, and other products, together with antennas. The Interconnect and Sensor Systems segment is involved in the design, manufacture, and marketing of sensors, sensor-based systems, connectors, and value-add interconnect systems. The company was founded by Schmitt J. Arthur in 1932 and is headquartered in Wallingford, CT.

Amphenol Corp. - Ordinary Shares - Class A

Amphenol is trending due to robust earnings results, showcasing strong growth in its AI-driven datacom business and strategic acquisitions. The community is actively discussing its pivotal role as a key infrastructure provider for hyperscalers, viewing recent market dips as prime buying opportunities amidst widespread analyst optimism.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix is trending amidst significant community buzz surrounding its impending v3 Perps launch on Ethereum Mainnet, which heralds an end to token inflation and the start of buybacks. This, coupled with a highly anticipated $1M trading competition and speculation around a potential Robinhood listing, is driving calls to "buy the dip" as investors eye a major breakout for the protocol.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending amid an intense debate over the "AI disruption" narrative, with investors selling off software stocks due to concerns about Anthropic's Claude AI and recent analyst downgrades. Conversely, many in the community contend that CRM is severely undervalued and oversold, pointing to strong financials, potential for significant share buybacks, and its capacity to integrate AI as catalysts for a rebound.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is actively discussed amid a recent clinical trial approval for Huntington's Disease and expectations of an expedited regulatory environment for rare disease treatments. The community highlights the stock's significant undervaluation given robust Elevidys sales and its promising siRNA pipeline, fueling speculation around a potential short squeeze or strategic acquisition despite current volatility.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is surging following strong earnings and optimistic guidance, fueled by robust demand for optical components critical to the rapidly expanding AI data center infrastructure. The community is sharply divided between those celebrating its parabolic rise as a pivotal AI play and others warning of extreme overvaluation and significant insider selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Arcadia CEO TJ Schaefer stated that, following the termination of the merger agreement, the company will resume evaluating its strategic alternatives to create value for shareholders.</li><li>Schaefer added that the company owns 2.7 million shares of Above Food Ingredients.</li><li>He also stated that Arcadia is entitled to additional compensation and consideration for the sale of its GoodWheat brand to Above Food.</li></ul>Arcadia Biosciences Inc. (RKDA) shares rose more than 7% in Friday’s pre-market trade before losing all the gains and hovering 1% lower. This is after the company announced that it had received a merger termination notice from Roosevelt Resources.Arcadia and Roosevelt had entered into a business combination agreement in December 2024 in the form of an all-stock transaction.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/RKDA">Arcadia Biosciences</a> trended in the ‘neutral’ territory at the time of writing.<h2 class="st-heading-2">Resuming Evaluation Of Strategic Alternatives</h2>Arcadia CEO TJ Schaefer stated that, following the termination of the merger agreement, the company will resume evaluating its strategic alternatives to create value for shareholders.“Over the last two-and-a-half years, we have streamlined our operations, significantly reduced our operating expenses and grown the Zola coconut water brand while avoiding the use of long-term debt,” he said.Schaefer added that the company owns 2.7 million shares of Above Food Ingredients. He also stated that Arcadia is entitled to additional compensation and consideration for the sale of its GoodWheat brand to Above Food.Arcadia sold the GoodWheat brand to Above Food for $4 million in May 2024.Following the merger announcement with Roosevelt in 2024, Arcadia stated that the new entity would be named Roosevelt Resources Inc., with the company listing under a new symbol.Arcadia’s shareholders would own 10% of the new entity, while Roosevelt shareholders would own the remaining 90%, the company stated while announcing the merger in 2024.<h2 class="st-heading-2">What Does Arcadia Do?</h2>Arcadia Biosciences is a California-based agricultural biotechnology company that focuses on developing crop traits to enhance their quality and productivity.Founded in 2002, the company has developed soybean varieties carrying the drought-tolerant HB4 trait in a joint venture with Bioceres Crop Solutions Corp. (BIOX).<a href="https://stocktwits.com/symbol/RKDA">RKDA stock</a> is down 49% year-to-date and 51% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/treasury-yields-muted-considerably-slower-gdp-q4/cLeUB3gREwY">Treasury Yields Hold Steady As Wall Street Braces For ‘Considerably Slower’ Q4 GDP</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

RKDA Stock Edges Lower After Company Receives Merger Termination Notice From Roosevelt Resources

Arcadia and Roosevelt had entered into a business combination agreement in December 2024 in the form of an all-stock transaction.

Equity

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders PR...

Arcadia Biosciences Inc. shares soared more than 200% Thursday morning, reaching levels not seen since March 2023, after the company announced a transformative merger with Roosevelt Resources LP.The two firms have entered into a definitive securities exchange agreement to combine in an all-stock transaction.&nbsp;Arcadia, an agricultural biotechnology company, will issue shares of its common stock to Roosevelt’s partners in exchange for all equity interests in the privately held exploration and production company.&nbsp;Roosevelt’s assets include projects for carbon-capture utilization, storage, and oil and natural gas production.Post the merger, Roosevelt’s current equity holders are expected to own approximately 90% of the combined company’s outstanding shares, with Arcadia shareholders holding the remaining 10%, subject to adjustments as outlined in the agreement.&nbsp;The deal, anticipated to close in the first quarter of 2025 or later, hinges on customary regulatory approvals and closing conditions.Arcadia CEO T.J. Schaefer emphasized the strategic rationale, stating that since July 2023, the company has undertaken a strategic review to maximize shareholder value.&nbsp;“During that time, we have streamlined our operations to focus on Zola coconut water, reduced operating expenses and generated non-dilutive capital through the sale of our GoodWheat brand and our wheat IP,” he said.“After a comprehensive and prolonged review, we have concluded that a business combination with Roosevelt Resources is the best alternative to create value for Arcadia and its shareholders.”The merged entity will adopt the Roosevelt Resources name and trade on the Nasdaq under a new symbol.<figure class="image"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/RKDA_sentiment_and_message_volume_Dec_5_6edb2b66cb.png" alt="RKDA sentiment and message volume Dec 5.png" width="1318" height="318"><figcaption>RKDA sentiment and message volume Dec 5 as of 11:00 am ET | source: Stocktwits</figcaption></figure>Retail investors on Stocktwits celebrated the news, driving sentiment for RKDA to ‘extremely bullish’ amid the ticker appearing among the top five trending symbols on Thursday morning.&nbsp;A user shared a screenshot of their long-term position initiated in 2021 at $2.61, remarking, “Three years of holding… and today paid off.”&nbsp;<stembedurl>https://stocktwits.com/jacksparo/message/595196398</stembedurl>Another user predicted a rally to $20–$30 by day’s end, citing the stock’s low float of just 1.36 million shares.<stembedurl>https://stocktwits.com/cjstocksup/message/595199468</stembedurl>With Thursday’s meteoric rise, Arcadia’s year-to-date gains have climbed to 150%, vastly outperforming the S&amp;P 500’s 27.47% increase.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Post the merger, Roosevelt’s current equity holders are expected to own approximately 90% of the combined company’s outstanding shares, with Arcadia shareholders holding the remaining 10%.

Arcadia Biosciences Stock Triples On Merger Deal With Roosevelt Resources: Retail Elated

Arcadia, an agricultural biotechnology company, will issue shares of its common stock to Roosevelt’s partners in exchange for all equity interests in the privately held exploration and production company. 

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include Zola coconut water and agronomic wheat traits. It operates through the following geographical segments: United States, Argentina, India, and Canada. The company was founded by John G. Sperling in 2002 and is headquartered in Dallas, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.66	--	--	N/A
Q3 '25	-$0.54	-$0.85	-57.01%	MISSED
Q2 '25	-$0.79	-$3.26	-312.66%	MISSED
Q1 '25	-$0.98	$1.90	293.88%	BEAT
Q4 '24	-$0.89	-$2.98	-234.83%	MISSED

RKDA
Arcadia Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest RKDA News

RKDAArcadia Biosciences Inc